BNP Paribas Exane downgraded Sonova (SONVY) to Underperform from Outperform with a CHF 215 price target The company’s product momentum tailwinds are easing, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONVY: